The Incidence of Ocular Complications in Candidemic Patients and Implications for the Practice of Routine Eye Exams
- PMID: 35355893
- PMCID: PMC8962754
- DOI: 10.1093/ofid/ofac045
The Incidence of Ocular Complications in Candidemic Patients and Implications for the Practice of Routine Eye Exams
Abstract
Background: Ocular candidiasis is a known complication of candidemia. Given the poor ocular penetration of echinocandins, there is some concern that the increasing use of echinocandins may portend an increased incidence of ophthalmic complications. We examined the changing trends in antifungal prescribing patterns and the incidence of ophthalmic complications after candidemia.
Methods: Patients with blood cultures positive for Candida species between January 2014 and June 2020 who underwent screening fundoscopic examination by an ophthalmologist were analyzed. The χ2 analysis was used to compare antifungal prescriptions and ocular exam findings before and after 2016. Trend analysis was also performed to assess temporal changes in prescribing practices and eye exam findings.
Results: There were 226 candidemia cases during the study period, 129 (57.1%) of which underwent screening eye exams. From 2014 to 2015, 24 of 37 (64.5%) patients received eye-penetrating antifungals compared to 36 of 92 (39.1%) from 2016 to 2020 (P = .008). Overall, 30 of 129 (23.3%) patients had abnormal eye exams with the prevalence of abnormal findings being 7 of 37 (18.9%) before 2016 compared to 23 of 92 (25%, P = .46) thereafter. A trend analysis revealed an increase in abnormal eye findings over the study period (P = .008). Of the 30 patients who had abnormal eye exams, 9 (30%) had a change in systemic antifungal therapy from echinocandins to eye-penetrating antifungals. Echinocandin use was associated with abnormal eye findings.
Conclusions: Prescription of eye-penetrating antifungals for candidemia has trended down since 2016. This was associated with a concomitant increase in abnormal findings on screening fundoscopy. Abnormal eye exams were not uncommon throughout our study period.
Keywords: candidemia guidelines; echinocandins; endopthalmitis; ocular candidiasis; routine eye-screening.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures
Similar articles
-
No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins.Diagn Microbiol Infect Dis. 2017 Jun;88(2):141-144. doi: 10.1016/j.diagmicrobio.2017.02.014. Epub 2017 Feb 27. Diagn Microbiol Infect Dis. 2017. PMID: 28366609
-
Duration of treatment for candidemia and risk for late-onset ocular candidiasis.Infection. 2013 Feb;41(1):129-34. doi: 10.1007/s15010-012-0369-8. Epub 2012 Dec 2. Infection. 2013. PMID: 23212461
-
Do Patients With Candidemia Need an Ophthalmologic Examination?Open Forum Infect Dis. 2024 Nov 7;11(12):ofae663. doi: 10.1093/ofid/ofae663. eCollection 2024 Dec. Open Forum Infect Dis. 2024. PMID: 39691288 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients.Curr Opin Infect Dis. 2020 Dec;33(6):441-448. doi: 10.1097/QCO.0000000000000684. Curr Opin Infect Dis. 2020. PMID: 33044240 Review.
Cited by
-
On the American Academy Recommendations for cancelling routine screening for ocular candidiasis - are we being too hasty?Eye (Lond). 2024 Sep;38(13):2483-2484. doi: 10.1038/s41433-024-02999-1. Epub 2024 Mar 14. Eye (Lond). 2024. PMID: 38486119 Free PMC article. No abstract available.
-
Candidemia Treatment is Improved by Infectious Disease Consultation: A Population-Based Cohort Study.J Assoc Med Microbiol Infect Dis Can. 2024 Oct 25;9(3):129-139. doi: 10.3138/jammi-2024-0001. eCollection 2024 Oct. J Assoc Med Microbiol Infect Dis Can. 2024. PMID: 40556807 Free PMC article.
-
Epidemiology, Risk Factors and Clinical Outcome of Candidaemia: A decade-long experience at a university hospital in Oman.Sultan Qaboos Univ Med J. 2025 May 2;25(1):233-241. doi: 10.18295/2075-0528.2832. Sultan Qaboos Univ Med J. 2025. PMID: 40641720 Free PMC article.
-
Fungal Pulmonary Coinfections in COVID-19: Microbiological Assessment, Inflammatory Profiles, and Clinical Outcomes.Biomedicines. 2025 Apr 3;13(4):864. doi: 10.3390/biomedicines13040864. Biomedicines. 2025. PMID: 40299432 Free PMC article.
-
Screening, prevalence, and risk factors for secondary localization during candidemia in intensive care unit patients: the French CandidICU multicenter study.Crit Care. 2025 Jul 5;29(1):281. doi: 10.1186/s13054-025-05527-z. Crit Care. 2025. PMID: 40618139 Free PMC article.
References
-
- Huynh N, Chang HYP, Borboli-Gerogiannis S.. Ocular involvement in hospitalized patients with candidemia: analysis at a Boston tertiary care center. Ocul Immunol Inflamm 2012; 20:100–3. - PubMed
-
- Breazzano MP, Day HR, Bloch KC, et al. . Utility of ophthalmologic screening for patients with Candida bloodstream infections: a systematic review. JAMA Ophthalmol 2019; 137:698–710. - PubMed
-
- Vinikoor MJ, Zoghby J, Cohen KL, Tucker JD.. Do all candidemic patients need an ophthalmic examination? Int J Infect Dis 2013; 17:e146–8. - PubMed